Tagged anti-inflammatory
Press Release
Gb Sciences Co-Publishes Study Demonstrating Anti-Inflammatory Properties of Cannabis Ingredients
As published in the journal Food and Chemical Toxicology, the biopharmaceutical drug development firm's sponsored research used co-cultured human, primary immune cells as a model to evaluate the ability of selected Cannabis constituents to decrease inflammation. Read More
Press Release
GB Sciences Announces Issuance of US Patent for Its Proprietary, Cannabinoid-Based Anti-Inflammatory Formulations
This is the third U.S. patent awarded to GBS's disease-specific Cannabinoid-Containing Complex Mixtures (CCCM™), which further validates GB Sciences' drug discovery platform and strengthens its intellectual property patent portfolio Read More
Press Release
GB Sciences Files Provisional Patent Application for the Treatment of COVID-19-Related Acute Respiratory Distress Syndrome (ARDS), the Leading Cause of Hospitalization and Deaths, Utilizing Its Cannabinoid Containing Complex Mixtures (CCCM™)
Based on data from a two-year study, GBS's CCCM were designed for the treatment of Cytokine Storm Syndromes, while preserving anti-viral immune reactions Read More
Press Release
Is Chocolate Good for the Teeth? A Practical Outlook from the Sacramento Dentistry Group
A recent survey by a dental insurance company indicated that dentists prefer their patients eat chocolate over all other types of candy. Why does the popularity of this confection in the public eye match with its acceptance by many dentists? Read More
Press Release